Skip to main content
. 2015 Feb 4;7(2):999–1020. doi: 10.3390/nu7020999

Table 1.

Effects of treatments on blood biochemistry and hepatic parameters in MCS-diet-or MCD-diet-fed mice receiving four-weeks of treatment.

Parameter MCS Diet MCD Diet
Vehicle Vehicle 6-Gingerol (mg/kg/day) Ciprofibrate
25 50 100 (10 mg/kg/day)
Initial body weight (BW) (g) 21.13 ± 1.54 21.09 ± 1.28 21.17 ± 1.49 21.03 ± 1.37 21.14 ± 1.62 21.20 ± 1.81
Final BW (g) 28.47 ± 1.83 14.87 ± 1.42 15.17 ± 1.68 15.47 ± 1.53 15.21 ± 1.73 15.39 ± 1.84
Liver absolute weight (g) 1.41 ± 0.12 0.49 ± 0.06 0.52 ± 0.08 0.56 ± 0.06 0.58 ± 0.04 0.59 ± 0.06
Liver relative weight (%) 4.91 ± 0.27 c 3.30 ± 0.31 a 3.42 ± 0.26 a 3.62 ± 0.22 a 3.85 ± 0.25 a 3.90 ± 0.29 a
Plasma glucose (mg/dL) 95.12 ± 2.64 c 81.17 ± 4.17 a 82.24 ± 3.83 a 84.45 ± 3.26 a 83.33 ± 3.94 a 81.26 ± 4.03 a
Plasma TC (mg/dL) 153.90 ± 3.96 d 25.39 ± 4.28 b 24.36 ± 4.63 b 24.26 ± 4.48 b 25.65 ± 4.12 b 26.52 ± 3.91 b
Plasma TG (mg/dL) 98.81 ± 3.02 d 52.36 ± 3.11 b 57.52 ± 3.73 b 53.91 ± 3.96 b 52.49 ± 4.02 b 56.30 ± 3.24 b
Plasma ALT (U/L) 50.61 ± 6.27 d 297.14 ± 16.23 b 248.41 ± 15.78 b,c 180.44 ± 14.56 b,c 124.45 ± 12.47 a,d 94.23 ± 10.87 a,d
Plasma AST (U/L) 115.21 ± 10.91 d 464.85 ± 17.79 b 386.03 ± 16.55 b,c 280.11 ± 17.35 b,c 207.29 ± 18.40 a,d 166.25 ± 13.24 a,d
Hepatic TC (µmol/g liver) 12.23 ± 0.62 d 20.64 ± 1.16 b 18.82 ± 1.27 b,c 17.04 ± 1.04 b,c 15.22 ± 1.17 a,c 14.56 ± 1.46 a,d
Hepatic TG (µmol/g liver) 9.16 ± 0.82 d 18.61 ± 1.28 b 15.52 ± 1.17 b 13.18 ± 1.51 b,c 11.77 ± 1.09 a,c 11.06 ± 1.21 d

The vehicle (distilled water) used to prepare the tested medication solution was given at the same volume. Values (mean ± SD) were obtained from each group of eight animals in each group after four weeks of the experimental period. a p < 0.05 and b p < 0.01 compared to the values of vehicle-treated MCS-diet fed mice in each group, respectively. c p < 0.05 and d p < 0.01 compared to the values of vehicle-treated MCD-diet fed mice in each group, respectively.